Opiant Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-04-30
|
-1.70
|
0.00
|
1.70
|
100.00%
|
|
2023-01-31
|
-2.07
|
0.00
|
2.07
|
100.00%
|
|
2022-10-31
|
-1.49
|
-1.92
|
-0.43
|
-28.86%
|
|
2022-07-31
|
-1.36
|
-2.31
|
-0.95
|
-69.85%
|
|
2022-04-30
|
-0.91
|
-2.43
|
-1.52
|
-167.03%
|
|
2022-01-31
|
-0.01
|
0.11
|
0.12
|
1200.00%
|
|
2021-10-31
|
0.21
|
0.56
|
0.35
|
166.67%
|
|
2021-07-31
|
-0.28
|
0.31
|
0.59
|
210.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-10-31
|
-1.92
|
|
2022-07-31
|
-4.07
|
|
2021-07-31
|
-0.36
|
|
2020-07-31
|
1.72
|
|
2019-07-31
|
-0.82
|
|
2018-07-31
|
-3.76
|
|
2017-07-31
|
2.89
|
|
2016-07-31
|
-4.85
|
|
2015-07-31
|
-3.39
|
|
2014-07-31
|
-6.64
|
|
2013-07-31
|
-3.25
|
|
2012-07-31
|
-11.09
|
|
2011-07-31
|
-12.67
|
|
2010-07-31
|
-1.87
|